Research and Development

Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …

Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …

Researchers from Vanderbilt University have discovered a previously unknown ability of a compound in mother’s milk to protect new-borns from …

Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …

A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …

Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …

A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …

British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …

Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …

Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …

A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …

A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …